Koyfin Home > Directory > Health Care > Adamas Pharma > Return on Capital %

Adamas Pharma Return on Capital % Chart (ADMS)

Adamas Pharma annual/quarterly Return on Capital % from 2013 to 2020.
  • Adamas Pharma Return on Capital % for the quarter ending June 06, 2020 was -15.64 a -96.80% increase of 15.14 year over year
  • Adamas Pharma Return on Capital % for the last 12 months ending June 06, 2020 was -27.01 a -13.06% increase of 3.53 year over year
  • Adamas Pharma Annual Return on Capital % for 2019 was -32.66 a -16.54% increase of 5.40 from 2018
  • Adamas Pharma Annual Return on Capital % for 2018 was -38.06 a 4.01% decrease of -1.53 from 2017
  • Adamas Pharma Annual Return on Capital % for 2017 was -36.53 a 15.99% decrease of -5.84 from 2016
Other Margins & Efficiency Metrics:
  • Adamas Pharma EBITDA Margin for the quarter ending December 12, 2018 was $-187m a 135.57% decrease of -254m year over year
  • Adamas Pharma Return on Equity % for the quarter ending September 09, 2018 was -103.21 a -49.69% increase of 51.29 year over year
View Chart On Koyfin

Quarterly ADMS Return on Capital % Data

06/2020-15.64
03/2020-25.40
12/2019-36.68
09/2019-30.79
06/2019-29.44
03/2019-33.02
12/2018-28.83
09/2018-29.66
06/2018-28.28
03/2018-34.82

Annual ADMS Return on Capital % Data

2019-32.66
2018-38.06
2017-36.53
2016-30.69
2015-27.27
201410.10
201363.74
201278.83